EP3977986A4 - GASTRO-RESISTANT TABLET CONTAINING DIMETHYL FUMARATE - Google Patents
GASTRO-RESISTANT TABLET CONTAINING DIMETHYL FUMARATE Download PDFInfo
- Publication number
- EP3977986A4 EP3977986A4 EP20815090.4A EP20815090A EP3977986A4 EP 3977986 A4 EP3977986 A4 EP 3977986A4 EP 20815090 A EP20815090 A EP 20815090A EP 3977986 A4 EP3977986 A4 EP 3977986A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- tablet containing
- dimethyl fumarate
- containing dimethyl
- enteric tablet
- enteric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- LDCRTTXIJACKKU-ONEGZZNKSA-N dimethyl fumarate Chemical compound COC(=O)\C=C\C(=O)OC LDCRTTXIJACKKU-ONEGZZNKSA-N 0.000 title 1
- 229960004419 dimethyl fumarate Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/225—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Hospice & Palliative Care (AREA)
- Gastroenterology & Hepatology (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20190064576 | 2019-05-31 | ||
PCT/KR2020/006647 WO2020242132A1 (ko) | 2019-05-31 | 2020-05-21 | 디메틸푸마르산염을 함유한 장용성 정제 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3977986A1 EP3977986A1 (en) | 2022-04-06 |
EP3977986A4 true EP3977986A4 (en) | 2022-07-20 |
Family
ID=73553277
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20815090.4A Withdrawn EP3977986A4 (en) | 2019-05-31 | 2020-05-21 | GASTRO-RESISTANT TABLET CONTAINING DIMETHYL FUMARATE |
Country Status (10)
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2020283238B2 (en) * | 2019-05-31 | 2022-07-07 | Curacle Co., Ltd. | Enteric tablet containing dimethyl fumarate |
KR20220133807A (ko) | 2021-03-25 | 2022-10-05 | 주식회사 큐라클 | 특정 약동학적 매개변수를 나타내는 디메틸푸마레이트를 유효성분으로 함유한 약학적 조성물 |
KR20240069303A (ko) * | 2022-11-11 | 2024-05-20 | 주식회사 대웅제약 | 방출 제어형 약학적 조성물 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016081355A1 (en) * | 2014-11-17 | 2016-05-26 | Biogen Ma Inc. | Methods of treating multiple sclerosis |
WO2017056107A1 (en) * | 2015-09-28 | 2017-04-06 | Natco Pharma Ltd | Pharmaceutical compositions of dimethyl fumarate |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19848260C2 (de) | 1998-10-20 | 2002-01-17 | Fumapharm Ag Muri | Fumarsäure-Mikrotabletten |
DE19853487A1 (de) | 1998-11-19 | 2000-05-25 | Fumapharm Ag Muri | Verwendung von Dialkylfumaraten |
KR20090028047A (ko) | 2007-09-13 | 2009-03-18 | 경북대학교 산학협력단 | 디메틸푸마레이트의 신규 용도 |
KR20100066742A (ko) * | 2008-12-10 | 2010-06-18 | 삼일제약주식회사 | 안정화된 프로톤 펌프 억제제 함유 약학 조성물 |
CN102369000A (zh) * | 2009-01-09 | 2012-03-07 | 前进制药公司 | 包含一种或多种富马酸酯的药用组合物 |
EP2424357A4 (en) | 2009-04-29 | 2012-10-10 | Biogen Idec Inc | TREATMENT OF NERVOUS GENERATION AND NERVE IGNITION |
KR101379427B1 (ko) * | 2013-02-13 | 2014-03-28 | 경북대학교병원 | 디메틸푸마레이트를 유효성분으로 포함하는 신섬유증의 예방 또는 치료용 조성물 |
EP3492072A1 (en) * | 2013-08-26 | 2019-06-05 | Fwp Ip Aps | Pharmaceutical composition containing dimethyl fumarate for administration at a low daily dose |
CN105813634A (zh) * | 2013-12-12 | 2016-07-27 | 阿尔米雷尔有限公司 | 包含反丁烯二酸二甲酯的药物组合物 |
EP3110408B1 (en) * | 2014-02-28 | 2019-01-16 | Banner Life Sciences LLC | Controlled release enteric soft capsules of fumarate esters |
CN104288774B (zh) * | 2014-04-21 | 2018-10-09 | 河南省健康伟业生物医药研究股份有限公司 | 一种肠溶包衣、富马酸二甲酯肠溶制剂及其制备方法 |
CN104352441B (zh) * | 2014-10-16 | 2017-06-09 | 山东百诺医药股份有限公司 | 一种富马酸二甲酯肠溶微丸及其制备方法 |
MA40982A (fr) * | 2014-11-19 | 2017-09-26 | Biogen Ma Inc | Formulation de bille pharmaceutique comprenant du fumarate de diméthyle |
KR102283582B1 (ko) * | 2014-12-23 | 2021-07-30 | 한미약품 주식회사 | 푸마르산 에스테르를 함유하는 미니-정제 형태의 약제학적 제제 |
HRP20211269T1 (hr) * | 2015-02-08 | 2022-01-21 | Alkermes Pharma Ireland Limited | Kompozicije prolijeka na bazi monometil fumarata |
WO2016147108A1 (en) * | 2015-03-17 | 2016-09-22 | Hetero Research Foundation | Pharmaceutical compositions of dimethyl fumarate |
AU2016273068A1 (en) * | 2015-06-01 | 2017-12-21 | Sun Pharmaceutical Industries Ltd. | Pharmaceutical compositions of dimethyl fumarate |
CN104971048B (zh) * | 2015-07-01 | 2019-01-18 | 上海汇伦医药科技有限公司 | 富马酸二甲酯肠溶微丸及其制备方法 |
ES2900975T3 (es) * | 2015-12-31 | 2022-03-21 | Zakl Farmaceutyczne Polpharma Sa | Preparación farmacéutica oral con revestimiento entérico que comprende fumarato de dimetilo |
GR1009149B (el) * | 2016-10-25 | 2017-10-31 | Φαρματεν Αβεε | Φαρμακευτικα σκευασματα που περιλαμβανουν εναν εστερα φουμαρικου οξεως και μεθοδος παραγωγης αυτων |
AU2020283238B2 (en) * | 2019-05-31 | 2022-07-07 | Curacle Co., Ltd. | Enteric tablet containing dimethyl fumarate |
-
2020
- 2020-05-21 AU AU2020283238A patent/AU2020283238B2/en active Active
- 2020-05-21 WO PCT/KR2020/006647 patent/WO2020242132A1/ko unknown
- 2020-05-21 KR KR1020200060727A patent/KR102197465B1/ko active IP Right Grant
- 2020-05-21 EP EP20815090.4A patent/EP3977986A4/en not_active Withdrawn
- 2020-05-21 MX MX2021012441A patent/MX2021012441A/es unknown
- 2020-05-21 US US17/441,256 patent/US20220087942A1/en not_active Abandoned
- 2020-05-21 JP JP2021557880A patent/JP7224067B2/ja active Active
- 2020-05-21 BR BR112021018452-0A patent/BR112021018452B1/pt active IP Right Grant
- 2020-05-21 CA CA3135946A patent/CA3135946C/en active Active
- 2020-05-21 CN CN202080025339.0A patent/CN113645962A/zh active Pending
-
2022
- 2022-11-04 JP JP2022177059A patent/JP2023026417A/ja active Pending
-
2024
- 2024-02-14 US US18/441,957 patent/US20240180841A1/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016081355A1 (en) * | 2014-11-17 | 2016-05-26 | Biogen Ma Inc. | Methods of treating multiple sclerosis |
WO2017056107A1 (en) * | 2015-09-28 | 2017-04-06 | Natco Pharma Ltd | Pharmaceutical compositions of dimethyl fumarate |
Also Published As
Publication number | Publication date |
---|---|
CA3135946C (en) | 2022-08-09 |
JP2023026417A (ja) | 2023-02-24 |
CA3135946A1 (en) | 2020-12-03 |
JP7224067B2 (ja) | 2023-02-17 |
MX2021012441A (es) | 2022-10-07 |
BR112021018452B1 (pt) | 2022-10-04 |
JP2022519933A (ja) | 2022-03-25 |
US20240180841A1 (en) | 2024-06-06 |
KR20200138005A (ko) | 2020-12-09 |
BR112021018452A2 (US07803786-20100928-C00028.png) | 2021-12-21 |
KR102197465B1 (ko) | 2020-12-31 |
CN113645962A (zh) | 2021-11-12 |
US20220087942A1 (en) | 2022-03-24 |
WO2020242132A1 (ko) | 2020-12-03 |
EP3977986A1 (en) | 2022-04-06 |
AU2020283238A1 (en) | 2022-01-06 |
AU2020283238B2 (en) | 2022-07-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3977986A4 (en) | GASTRO-RESISTANT TABLET CONTAINING DIMETHYL FUMARATE | |
EP3910244A4 (en) | STOVE | |
EP4003477A4 (en) | MODULAR HEADWEAR | |
EP3945954A4 (en) | WATER HEATER | |
EP3836173A4 (en) | REACTOR | |
GB201911794D0 (en) | Headgear | |
EP3764973A4 (en) | STOMACH-RESISTANT SOFT GEL CAPSULES | |
GB2593861B (en) | Sync group selection | |
EP4003868A4 (en) | CONTAINER | |
EP3842356A4 (en) | CONTAINER | |
EP3768094A4 (en) | ENTERAL SOFT GEL CAPSULES | |
EP4029418A4 (en) | COOKING APPLIANCE | |
EP3995409A4 (en) | CONTAINER | |
EP3942974A4 (en) | STOVE | |
EP3870004A4 (en) | KETTLE | |
EP3811976A4 (en) | GASTRO-RESISTANT HARD CAPSULE | |
EP3949800A4 (en) | TWIST CONTAINER | |
EP3944475A4 (en) | SHIP GENERATOR | |
EP3920199A4 (en) | TRANSFORMER | |
EP3836174A4 (en) | REACTOR | |
TWI849216B (zh) | 含有乳鐵蛋白的腸溶片 | |
AU2019902965A0 (en) | Kettle | |
AU2019901058A0 (en) | Kettle | |
EP3943187A4 (en) | REACTOR | |
AU2019902737A0 (en) | Modular Headgear |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20210927 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20220620 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 9/20 20060101ALI20220614BHEP Ipc: A61P 43/00 20060101ALI20220614BHEP Ipc: A61P 19/02 20060101ALI20220614BHEP Ipc: A61P 17/06 20060101ALI20220614BHEP Ipc: A61K 31/225 20060101ALI20220614BHEP Ipc: A61K 9/28 20060101AFI20220614BHEP |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
RAP3 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: CURACLE CO., LTD. |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20230201 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
INTG | Intention to grant announced |
Effective date: 20230918 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20240130 |